Health
Researchers develop a recombinant SARS-CoV-2 receptor-binding domain trimer vaccine candidate – News-Medical.Net
New research deals with the development of RBD trimer as a potent target for SARS-CoV-2 subunit vaccines. This study revealed the development of a trimeric RBD…
The ongoing global pandemic of coronavirus disease 2019 (COVID-19) is caused by the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) pathogen. This virus has infected more than 128 million individuals and has claimed about 2.8 million lives.
Several COVID-19 vaccines have been approved by various regulatory bodies and are currently being rolled out across many parts of the world. There are more than 200 COVID-19 vaccines under development, and 70 are undergoing clinical trials. Several…
-
Noosa News14 hours agoFlatmates of missing teen Pheobe Bishop, 17, identified
-
Noosa News16 hours agoTully Sugar Mill celebrates 100 years of cane harvesting amid floods and cyclones
-
General19 hours agoOne person dead after house fire in Melbourne’s south-east
-
Business12 hours agoHow these 5 ASX 200 stocks are smashing the benchmark this week